LimmaTech Biologics
Schlieren · Founded 2015
About LimmaTech Biologics
LimmaTech Biologics is a clinical-stage biotech company that develops vaccines to prevent life-threatening diseases. The company uses proprietary self-adjuvanting and multi-antigen vaccine platforms to address microbial infections that are becoming resistant to treatments. Its research and development efforts aim to create vaccines tailored to specific pathogens. LimmaTech Biologics works on expanding its pipeline to provide solutions for infectious diseases with limited treatment options.
Company Facts
- Founded: 2015
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $46.0M
- Funding stage: Early Stage Venture
- Last round: Grant (Feb 2025)
- Website: lmtbio.com
- Phone: +41 44 733 8585
Industries & Categories
Biopharma, Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/limmatech-biologics-42699 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.